- About GSN
- Contact us
The return to financial health of Ras Al-Khaimah (RAK)’s Gulf Pharmaceutical Industries (Julphar) is likely to be aided by a contract to produce the Covid-19 vaccine developed by Sinopharm China National Biotec Group and Abu Dhabi-based Group 42. The latter is linked to national security adviser Sheikh Tahnoun Bin Zayed.
(Access to one 100-400 word article)
Subscribe to Gulf States Newsletter